(855) leva - 594 info@renoviainc.com
  • Linkedin
  • Linkedin
Renovia Inc
  • leva ® Digital Therapeutic
    • What is Pelvic Health?
    • What is leva®?
    • How to get leva®?
    • Videos
  • For Patients
    • leva® FAQ
    • leva® Digital Therapeutic Instructions for Use
    • First-Generation leva® Instructions for Use
    • E-Sign Patient Authorization First-Generation leva®
  • Clinical Evidence
    • Renovia Clinical Trial
    • Pilot Study Publication
  • About
    • Leadership
    • Advisors
  • News
  • Careers
  • Contact
Select Page

LES005.3.09B Renovia Agreement 30Oct18 FINAL

by Renovia | Nov 26, 2018

LES005.3.09B-Renovia-Agreement-30Oct18-FINAL

Recent Press Releases

  • Meet The Company Offering An Innovative Medication-Free Approach To Better Pelvic Floor Health, Bringing Female Urinary Incontinence Out Of The Closet
  • Study shows leva® Digital Therapeutic improves fecal incontinence symptoms
  • Renovia raises $17M in Series C-1 financing
  • Renovia names new president and CEO; Completes enrollment for randomized controlled trial.
  • Renovia presents at Piper Sandler Healthcare Conference

Recent News

  • Meet The Company Offering An Innovative Medication-Free Approach To Better Pelvic Floor Health, Bringing Female Urinary Incontinence Out Of The Closet
  • Study shows leva® Digital Therapeutic improves fecal incontinence symptoms

Learn More

Renovia Inc.

263 Summer Street
Boston, MA 02210 

Corporate: (866) 735-8424
leva Women’s Center:
(855) leva – 594 or
(855) 538-2594
Fax: (888) 503-7788
info@renoviainc.com

  • Linkedin
© 2021 Renovia Inc. All rights reserved.

Privacy Policy | Terms and Conditions